Novel alternative promoters of mouse glial cell line-derived neurotrophic factor gene

被引:28
|
作者
Tanaka, M
Ito, S
Kiuchi, K
机构
[1] RIKEN, Chem Res Ctr, Nagoya, Aichi 4630003, Japan
[2] RIKEN, Inst Phys, Bio Mimet Control Res Program, Lab Genes Motor Syst, Nagoya, Aichi 4630003, Japan
关键词
GDNF gene; gene structure; alternative promoter; inflammatory cytokine; NF-kappa B;
D O I
10.1016/S0167-4781(00)00218-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously isolated cDNA and genomic DNA of the mouse glial cell line-derived neurotrophic factor (GDNF) gene and found that the gene consists of three exons. Recently, it was suggested that an alternative promoter exists within intron 1 of the human GDNF gene, but this has not been confirmed. Novel cDNA clones of the mouse GDNF gene were isolated by 5'-rapid amplification of cDNA ends from postnatal day-14 striatum. A novel exon, containing 351 nucleotides, exists between exon 1 and exon 3 (referred to as exon 2 in our previous report). Luciferase reporter assay showed that a core promoter for the novel exon 2 requires its 5'-untranslated region. Primer extension analysis and reverse transcription-PCR identified another novel transcript that starts 39 bp upstream of exon 3, and the core promoter activity exists within a region containing putative Spl sites. Although the core promoters for the novel exons are different from those previously identified, transcripts derived from each promoter coincidentally increased with interleukin-1 beta or tumor necrosis factor-alpha stimulation. Gel retardation assays suggested that the NF-kappaB binding site in intron 1 would be involved in the cytokine response of the mouse GDNF gene. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:63 / 74
页数:12
相关论文
共 50 条
  • [31] Chromaffin cell mitogenesis by neurturin and glial cell line-derived neurotrophic factor
    Powers, JF
    Schelling, KH
    Tischler, AS
    NEUROSCIENCE, 2001, 108 (02) : 341 - 349
  • [32] Mutation analysis of the glial cell line-derived neurotrophic factor gene in Parkinson's disease
    Wartiovaara, K
    Hytönen, M
    Vuori, M
    Paulin, L
    Rinne, J
    Sariola, H
    EXPERIMENTAL NEUROLOGY, 1998, 152 (02) : 307 - 309
  • [33] Cloning of glial cell line-derived neurotrophic factor gene and its expression in eukaryotic cells
    Jiang, Q
    Liu, J
    Ge, K
    Liu, WC
    Sun, LY
    Liu, XY
    Zheng, ZC
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 1999, 31 (02): : 150 - 154
  • [34] In vivo gene delivery of glial cell line-derived neurotrophic factor for Parkinson's disease
    Kordower, JH
    ANNALS OF NEUROLOGY, 2003, 53 : S120 - S132
  • [35] A commentary on glial cell line-derived neurotrophic factor (GDNF) - From a glial secreted molecule to gene therapy
    Bohn, MC
    BIOCHEMICAL PHARMACOLOGY, 1999, 57 (02) : 135 - 142
  • [36] Cloning of glial cell line-derived neurotrophic factor gene and purification of expressed product.
    Chen, Y
    Zhang, Y
    Li, JZ
    Deng, W
    Xia, LC
    Qiu, R
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 1996, 23 (06) : 556 - 557
  • [37] Identification of a novel glial cell line-derived neurotrophic factor-inducible gene required for renal branching morphogenesis
    Fukuda, N
    Ichihara, M
    Morinaga, T
    Kawai, K
    Hayashi, H
    Murakumo, Y
    Matsuo, S
    Takahashi, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (50) : 50386 - 50392
  • [38] Novel Magnetic Hydroxyapatite Nanoparticles as Non-Viral Vectors for the Glial Cell Line-Derived Neurotrophic Factor Gene
    Wu, Hsi-Chin
    Wang, Tzu-Wei
    Bohn, Martha C.
    Lin, Feng-Huei
    Spector, Myron
    ADVANCED FUNCTIONAL MATERIALS, 2010, 20 (01) : 67 - 77
  • [39] Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease
    Cunningham, LA
    Su, C
    EXPERIMENTAL NEUROLOGY, 2002, 174 (02) : 230 - 242
  • [40] Promotion of seminomatous tumors by targeted overexpression of glial cell line-derived neurotrophic factor in mouse testis
    Meng, XJ
    de Rooij, DG
    Westerdahl, K
    Saarma, M
    Sariola, H
    CANCER RESEARCH, 2001, 61 (08) : 3267 - 3271